Robert Wood Johnson Foundation

Menu
  • About RWJF
  • Our Work
  • Research & Publications
View All:
  • Grants
  • Topics
  • Blogs

Prescription Drugs and Services

You are now viewing 1 - 10 of 19 results

Sort results by:
  • Relevance
  • Alphabetical Order
  • Publication Date

Refine Your Results

  • Topic: Prescription drugs and services
  • Topic: Public policy and regulation
By Topic
  • Health policy (6)
  • Substance abuse treatment (6)
  • Health care system (6)
  • Government, policy and legal issues (5)
  • Drugs (illegal and Rx) (5)
  • Cost of care (4)
  • State government (4)
  • Quality of care (4)
  • Patient-centered care/family-centered care (3)
  • Patient-provider collaboration (3)
  • E-patients (3)
  • Observations of daily living (3)
  • Personal health monitoring (3)
  • Electronic health records (EHRs) (3)
  • Mobile health/mhealth (3)
By Content
  • Content Type
    • Program Result Report (9)
    • Journal Article (5)
    • Issue Brief (3)
    • Story (1)
    • Commentary (1)
  • Program Area
    • Vulnerable Populations (6)
    • Quality/Equality (5)
    • Human Capital (4)
    • Pioneer (4)
    • Public Health (2)
By Demographics
  • Age
    • Adults (19-64 years) (1)
    • Seniors (65+) (1)
  • Location
    • National (11)
    • Urban (1)
  • States and Territories
    • Oregon (OR) P (1)
    • Washington (WA) P (1)

More Nonelderly Americans Face Problems Affording Prescription Drugs

January 1, 2009 | Issue Brief

More children and working-age Americans are going without prescription drugs because of cost concerns, according to a new national study by the Center for Studying Health System Change (HSC).

Cost, Lack of Insurance Coverage, Anti-Medication Bias Limit Scripts of Naltrexone for Alcoholism

December 9, 2005 | Program Result Report

Richard A. Rawson, Ph.D., evaluated the reasons why naltrexone (a medication-based treatment for alcohol abuse and dependence and opiate addiction) is not widely used by physicians and practitioners.

Trends in Resistance to Carbapenems and Third-Generation Cephalosporins among Clinical Isolates of Klebsiella pneumoniae in the United States, 1999-2010

March 1, 2013 | Journal Article

Increases in the prevalence of drug-resistant pneumonia present a major infection control challenge for public health.

RWJF Investigator in Health Policy Research, Daniel Carpenter, PhD, Publishes New Book on the FDA

February 24, 2011 | Story

In 2003, he received an RWJF Investigator Award in Health Policy Research to probe more deeply into pharmaceutical policy at the FDA. The pursuit quickly broadened.

Using Market-Exclusivity Incentives to Promote Pharmaceutical Innovation

December 21, 2009 | Journal Article

Policy innovations to stimulate drug development succeed, but sometimes with unintended consequences.

Access to Prescription Drugs for Medicare Beneficiaries

March 1, 2009 | Issue Brief

Despite the introduction of a Medicare outpatient prescription drug benefit in January 2006, roughly the same proportion of elderly Medicare beneficiaries in 2003 and 2007--about 8 percent--skipped filling at least one prescription drug because of cost concerns, according to a new national study by the Center for Studying Health System Change.

State Prescription Drug Price Web Sites

February 1, 2008 | Issue Brief

How Useful to Consumers?

Tracking State Medical Marijuana Legislation and Ballot Initiatives

April 1, 2007 | Program Result Report

The National Conference of State Legislatures tracked state-level legislative and ballot initiatives involving the medical use of marijuana as part of the organization's Health Policy Tracking Service.

Study: Nicotine Gums and Patches Go OTC and More Smokers Try to Quit

June 3, 2006 | Program Result Report

Between July 2002 and June 2005, researchers at Roswell Park examined whether use of these nicotine replacement therapies (also called NRT) and smoking quit rates changed after reclassification.

Medications Work for Severely Addicted Smokers

January 1, 2005 | Commentary

Previous research has demonstrated that individuals who are severely addicted to cigarettes may have more difficulty quitting, higher rates of relapse and greater risk of smoking-related diseases than lighter smokers. The effectiveness of current to ...

  • 1
  • 2
  • Next
RWJF Home → Topics → Prescription Drugs and Services
  • Facebook
  • Twitter
  • YouTube
  • Email
  • RSS

Our mission: to improve the health and health care of all Americans.

  • About RWJF
    • Our Mission
    • Program Areas
    • From Our President
    • Leadership & Staff
    • Annual Reports
    • Newsroom
    • Job Opportunities
    • Office Location
    • Our Policies
  • Our Work
    • Health Policy
    • Prevention
    • Cost and Value
    • Leadership
    • All Topics
  • Program Areas
    • Childhood Obesity
    • Coverage
    • Human Capital
    • Pioneer
    • Public Health
    • Quality/Equality
    • Vulnerable Populations
  • Research & Publications
    • Find RWJF Research
    • Assessing Our Impact
    • How We Work
    • Data Center
    • RWJF DataHub
  • Grants
    • What We Fund
    • Calls for Proposals
    • Grantee Resources
    • FAQs
  • Blogs
    • Human Capital
    • New Public Health
    • Pioneering Ideas
  • My RWJF
    • Subscription Management
    • My Profile
  • Contact RWJF
  • Privacy Policy
  • Terms and Conditions

© 2001–2013 Robert Wood Johnson Foundation. All Rights Reserved.